Literature DB >> 31275078

Crohn's Disease and the Risk of Cancer.

Evie Carchman1.   

Abstract

Crohn's disease is associated with various intestinal and extraintestinal malignancies. This article reviews the current literature regarding Crohn's disease and subsequent risk of cancer formation. Recognition of risk factors (both modifiable and unmodifiable) is essential for prevention and appropriate screening. Future investigations into the molecular mechanisms associated with Crohn-related malignancy will provide additional insight into carcinogenesis, potential for early intervention, and identification of at-risk patients.

Entities:  

Keywords:  Crohn's disease; cancer; inflammatory bowel disease; malignancy

Year:  2019        PMID： 31275078      PMCID： PMC6606322          DOI： 10.1055/s-0039-1683923

Source DB:  PubMed          Journal:  Clin Colon Rectal Surg        ISSN： 1530-9681


  73 in total

1.  Small bowel adenocarcinoma in patients with Crohn's disease compared with small bowel adenocarcinoma de novo.

Authors:  Vanessa Palascak-Juif; Anne Marie Bouvier; Jacques Cosnes; Bernard Flourié; Olivier Bouché; Guillaume Cadiot; Marc Lémann; Bruno Bonaz; Christine Denet; Philippe Marteau; Luc Gambiez; Laurent Beaugerie; Jean Faivre; Franck Carbonnel
Journal:  Inflamm Bowel Dis       Date:  2005-09       Impact factor: 5.325

Review 2.  Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies.

Authors:  Tine Jess; Michael Gamborg; Peter Matzen; Pia Munkholm; Thorkild I A Sørensen
Journal:  Am J Gastroenterol       Date:  2005-12       Impact factor: 10.864

Review 3.  Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease.

Authors:  Steven H Itzkowitz; Daniel H Present
Journal:  Inflamm Bowel Dis       Date:  2005-03       Impact factor: 5.325

4.  [Cancer and Crohn's disease].

Authors:  R Winkler; A Wittmer; U Heusermann
Journal:  Z Gastroenterol       Date:  2002-08       Impact factor: 2.000

5.  PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis.

Authors:  E V Loftus; G C Harewood; C G Loftus; W J Tremaine; W S Harmsen; A R Zinsmeister; D A Jewell; W J Sandborn
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

6.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis.

Authors:  J A Eaden; K R Abrams; J F Mayberry
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

7.  Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine.

Authors:  A Kandiel; A G Fraser; B I Korelitz; C Brensinger; J D Lewis
Journal:  Gut       Date:  2005-08       Impact factor: 23.059

8.  Risk of haematopoietic cancer in patients with inflammatory bowel disease.

Authors:  J Askling; L Brandt; A Lapidus; P Karlén; M Björkholm; R Löfberg; A Ekbom
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

Review 9.  Extraintestinal manifestations of inflammatory bowel disease.

Authors:  C N Bernstein
Journal:  Curr Gastroenterol Rep       Date:  2001-12

10.  Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients.

Authors:  Bouthaina S Dabaja; Dima Suki; Barbara Pro; Mark Bonnen; Jaffer Ajani
Journal:  Cancer       Date:  2004-08-01       Impact factor: 6.860
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.